The QualityStocks Daily Stock List
- Advantage Lithium Corp. (AVLIF)
- American International Holdings Corp. (AMIH)
- Appliqate, Inc. (APQT)
- Celexus, Inc. (CXUS)
- General Cannabis Corp. (CANN)
- GrowGeneration Corp. (GRWG)
- Lifeloc Technologies, Inc. (LCTC)
- BioRestorative Therapies, Inc. (BRTX)
- ProGreen US, Inc. (PGUS)
- Micromem Technologies, Inc. (MMTIF)
- Kiwa Bio-Tech Products Group Corporation (KWBT)
- Acura Pharmaceuticals, Inc. (ACUR)
- Protalex, Inc. (PRTX)
- Sunvalley Solar, Inc. (SSOL)
Advantage Lithium Corp. (AVLIF)
The Bull Report, Mining News Feed, StockInvest.us, Market Screener, TipRanks, OTC Markets, Nasdaq, Streetwise Reports, The Prospector News, Gold Telegraph, Street Insider, Macroaxis, Market Wire News, Junior Mining Network, Morningstar, InvestorsHub, Investing News, Stockhouse, Wallet Investor, TradingView, Wallmine, GuruFocus, Investors Hangout, and GlobeNewswire reported previously on Advantage Lithium Corp. (AVLIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Advantage Lithium Corp. focuses on developing its 75 percent owned Cauchari lithium project, situated in Jujuy, Argentina (75 percent Advantage Lithium, 25 percent Orocobre Ltd.). Additionally, the Company owns 100 percent interest in three additional lithium exploration properties in Argentina. These are Antofalla, Incahuasi, and Guayatayoc. Advantage Lithium is based in Vancouver, British Columbia and lists on the OTC Markets Group’s OTCQX.
In essence, Advantage Lithium is a lithium explorer and developer with top tier management and an international portfolio of quality assets. It has a partnership with Orocobre, one of Argentina’s leading lithium producers, to develop its Cauchari asset. This asset hosts an inferred resource and includes a large exploration target. Orocobre is the largest single shareholder of Advantage Lithium.
The Cauchari Project encompasses roughly 28,000 hectares. It is less than 20km south of Orocobre’s producing Olaroz Plant. The Project is adjacent to an international highway, and has access to water and power. The Permitting process established with local governments is supportive. Orocobre is the only new lithium brine producer in the past 20 years.
Advantage Lithium announced this past October the results of a Pre-Feasibility Study (PFS) based on production of Battery Grade Lithium Carbonate from a 25 ktpa nameplate capacity stand-alone plant located at its Cauchari JV in the province of Jujuy, Argentina.
Callum Grant, Interim Chief Executive Officer said "The PFS now demonstrates that we have a solid project to a much improved level of confidence compared to the 2018 Preliminary Economic Assessment. Not only have we doubled the resource but more importantly those resources were upgraded to Measured and Indicated categories earlier in 2019. Now we have a Proven and Probable Mineral Reserve demonstrating the economic viability of the asset to support long-life supply of battery-grade Lithium Carbonate to the EV market; we're now at a different level where the value of the asset is clear.”
Recently, further to the news release of October 22, 2019, Advantage Lithium announced that it filed the full Pre-Feasibility (PFS) Technical Report on its Cauchari JV project. The PFS was completed by independent consulting firms FloSolution and Worley.
Advantage Lithium Corp. (AVLIF), closed Thursday's trading session at $0.24565, up 8.6947%, on 31,780 volume with 14 trades. The average volume for the last 3 months is 59,941 and the stock's 52-week low/high is $0.101599998/$0.535300016.
American International Holdings Corp. (AMIH)
Stocks to Buy, Wallet Investor, Last10k, Research Pool, Seeking Alpha, Investors Hub, GuruFocus, Market Screener, TipRanks, OTC Markets, GlobeNewswire, Nasdaq, Trading View, MarketWatch, Stockopedia, Simply Wall St, and Dividend Investor reported beforehand on American International Holdings Corp. (AMIH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
American International Holdings Corp. is a diversified holding company based in Houston, Texas. Its dedication is to acquiring, managing and operating health, wellness, beauty, and lifestyle companies, businesses and/or brands located in the United States and worldwide. The Company looks for opportunities to acquire and grow businesses that possess strong brand values and that can produce long-term sustainable free cash flow and attractive returns so as to maximize value for the Company and its stakeholders. Incorporated on August 18, 1986, American International Holdings lists on the OTC Markets.
American International Holdings owns and operates a medical spa under the Novopelle brand name in McKinney, Texas. This past October, the Company announced that it appointed Mr. JJ Dickens, as the Chief Executive Officer (CEO) of its newly created wholly-owned subsidiary, Capitol City Solutions USA, Inc. (CCS). CCS was created to act as a general contracting and construction company focused on the remodeling, general construction and interior finish of the Company’s newly formed Novopelle branded med spa locations and also to market to other commercial real estate projects within the U.S. Mr. Dickens brings more than 10 years of construction and project management experience to CCS.
American International Holdings also has its newly launched subsidiary, YS Brands, Inc. YS Brands was created as a wholly-owned subsidiary. Its commitment is to creating, designing, manufacturing and marketing new premium designer shoe concepts intended to sell through direct to consumer (retail and e-commerce) and wholesale via larger, bigger box retail stores.
Today, American International Holdings announced that its wholly-owned subsidiary, Capitol City Solutions USA, Inc. (CCS), executed a construction contract with a multi-family apartment investment and management company This contract is to provide water mitigation, demolition, interior finish out and remodeling, and flooring repairs for a multi-family apartment complex located in Beaumont, Texas.
The construction contract has a value of greater than $6,690,000, subject to adjustment and subject to draws being made under the agreement, over time, and subject to completion of demolition and construction services milestones. The anticipation is that the project will be completed by no later than June 1, 2020.
American International Holdings Corp. (AMIH), closed Thursday's trading session at $0.6299, up 4.9833%, on 20,501 volume with 23 trades. The average volume for the last 3 months is 43,261 and the stock's 52-week low/high is $0.550000011/$2.40000009.
Appliqate, Inc. (APQT)
Penny Stock Base, EIN Presswire, Penny Stock Hub, Stockhouse, Virtual Strategy, Dividend.com, TipRanks, Wallet Investor Market Wire News, Otc.watch, Investors Hangout, Stockwatch, Dividend Investor, Stockopedia, TradingView, MarketWatch, and GlobeNewswire reported previously on Appliqate, Inc. (APQT), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Appliqate, Inc.’s mission is to lead the future of payment processing for businesses by incorporating the method of blockchain payments. The Company is a blockchain payments platform that furthers the rise of an integrated open international blockchain economy. Appliqate has recruited and trained a substantial blockchain salesforce across 108 countries (Compaffiliates). Appliqate is based in Lehi, Utah. A Wyoming Corporation, the Company lists on the OTC Markets.
In combination with its ecosystem partners, Appliqate encourages the adoption of digital wallets (ABRA), retail crypto-currency transactions, and online cryptocurrency bill-pay (Cents). Constructed on the CompChain blockchain, and using CompCoin (CoCo) currency, the Company is positioned to be the first widely accepted blockchain payments platform.
CompChain is the Company’s network. Coco cryptocurrency is its money. CompChain members buy CoCo, CompChain’s core currency, in their CompChain wallets. Members use CoCo to cover basic membership functions.
Of note is that members will be able to use CoCo to directly buy from more than 100,000 retail locations as well as pay bills from any company that accommodates electronic bill pay. CompCoin is a mine-able SHA256 POW hashing algorithm.
CompChain is the world’s first publicly available, working blockchain payment processing system. It provides a real-time, accurate, transparent global payment solution and business growth platform for entrepreneurs.
Appliqate has attained another major feat with the recent acquisition of DocLoc. DocLoc is a secure location-based file-sharing. It has been described as “the Perfect solution for protecting all confidential documents and files.” The deal to acquire the platform was sealed and signed, making DocLoc the latest addition to the Appliqate team.
DocLoc is a user-friendly platform designed to enable users to send and retrieve their documents over the web and through email. The system is coming as a solution to the problem of compromised information because of threats from unauthorized parties such as hackers.
Appliqate, Inc. (APQT), closed Thursday's trading session at $3.06, up 0.327869%, on 300 volume with 1 trade. The average volume for the last 3 months is 464 and the stock's 52-week low/high is $0.029999999/$5.25.
Celexus, Inc. (CXUS)
Market Screener, Stockopedia, Simply Wall St, TeleTrader, Street Insider, PR Newswire, Invest Tribune, Dividend Investor, Last10k, OTC Markets, Investors Hangout, TradingView, Wallet Investor, Stockwatch, Stockhouse, GlobeNewswire, and InvestorsHub reported previously on Celexus, Inc. (CXUS), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Celexus, Inc. is an acquisition, management and holding company for high-trajectory agritech businesses and farming technologies. The OTCQB-listed Company was formerly known as Telupay International, Inc. As of February 2019, Celexus has agreed to acquire HempWave and operate it as a wholly-owned subsidiary. HempWave partners with farmers throughout the nation to grow, cultivate, and harvest commercial-grade hemp plants and seeds to produce medicinal grade cannabidiol (CBD oils) and other hemp by-products. Celexus is based in Arizona.
Fundamentally, Celexus operates as an acquisition, management, and holding company for early stage businesses and technologies in the hemp industry. It works to bring to market the best, most valuable innovations in the flourishing industrial hemp space. Celexus is actively assessing new acquisition candidates across the agriculture industry.
The Company’s aim is to control every aspect of the farming industry. This is from seeds to extraction and distribution. This eliminates reliance on third parties and ensures premier quality processes and production.
At the end of October, Celexus announced its new research and development division. In combination with small businesses and entrepreneurs, the Company is developing proprietary software using blockchain algorithms specific to the complexities of hemp biomass transactions. Additional technology in development includes drone mapping, soil nutrition, and data analytics, among others.
Celexus is investing in the technologies that will move agriculture, especially industrial hemp, into a growth market with far-reaching economic and environmental impact. This is to support its mission of growing a sustainable future.
At the end of December, HempWave announced its intention to purchase a controlling interest in Celexus from the present majority shareholders of Celexus. Celexus would subsequently change it’s name to Hempwave and become the brand of operations. The existing Hempwave will continue independent operations and would vend in new businesses into Celexus over a period of time. The deal is scheduled to close at the annual Shareholders meeting in Las Vegas, Nevada in May 2020.
Central to HempWave’s differentiated approach is the crop buyback program, announced earlier in 2019, in which HempWave guarantees a floor price based on CBD concentration percentage of the harvested biomass, up to current spot price, whichever is higher at the time. This policy solves for issues of uncertainty or potential loss, major obstacles in the ever-developing hemp market.
Celexus, Inc. (CXUS), closed Thursday's trading session at $0.59, up 28.233%, on 200 volume with 1 trade. The average volume for the last 3 months is 3,353 and the stock's 52-week low/high is $0.196600005/$1.95299994.
General Cannabis Corp. (CANN)
StreetWise Reports, Pot Stock Watch, Pot Stock News, Zacks, Daily Marijuana Observer, Micro Small Cap, Micro Cap Daily, OTC Markets, Simply Wall St, Stockhouse, YCharts, Infront Analytics, Insider Financial, CannabisMarketCap, The Street, and Green Rush Review reported earlier on General Cannabis Corp. (CANN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
General Cannabis Corp. is the comprehensive national resource to the regulated cannabis industry. The Company is a trusted partner to the cultivation, production and retail sides of the cannabis business. It was formerly known as Advanced Cannabis Solutions, Inc. It changed its name to General Cannabis Corp in June of 2015. General Cannabis has strong operating divisions including real estate, consulting, security, financing and the distribution of vital infrastructure products to grow facilities and dispensaries. OTCQX-listed, General Cannabis is based in Denver, Colorado.
General Cannabis’ family of brands include Next Big Crop (NBC); Chiefton; and Iron Protection Group (IPG). Next Big Crop (NBC) offers premier management and consulting services. NBC deploys proven solutions for every phase of medical and adult-use cannabis business operations. This is from licensure, design and construction, to the cultivation, manufacture and sale of medical-grade cannabis product.
Chiefton works to provide eco-friendly apparel, accessories, and printing techniques. Chiefton’s apparel and accessories use textiles such as hemp, organic cotton, and recycled polyester that deliver performance, comfort, and accountability. Moreover, Chiefton utilizes Denver’s only certifiably green screen-printing shop.
Iron Protection Group (IPG) is one of the fastest-growing security companies in the nation. IPG’s operators are U.S. Veterans. They are vigilant about education regarding regulations in order to ensure that compliance infuses every facet of its clients’ businesses. General Cannabis’ brands also include GC Capital (Capital Investments Real Estate); Next Big Crop (Operations Consultant and Products); and STOA Wellness (Consumer Goods).
This week, General Cannabis announced that it signed a non-binding term sheet to acquire Hälsa Holdings, Inc, a company led by industry experts and formed to acquire assets in mature markets. When the acquisition is complete, General Cannabis will acquire contracts to acquire three dispensaries in California, and add a very experienced team to its existing executive group. The expectation is that the acquisition will close in Q1 2020, subject to entry into definitive documentation.
Hälsa has entered into Purchase Agreements or Letters of Intent (LOIs) with three retail dispensaries in California. These collectively generate revenues of about $12 million. General Cannabis will seek to grow revenue at all three locations through refurbishing and expanding operations.
General Cannabis Corp. (CANN), closed Thursday's trading session at $0.6275, off by 1.9378%, on 36,562 volume with 103 trades. The average volume for the last 3 months is 181,301 and the stock's 52-week low/high is $0.50/$2.74.
GrowGeneration Corp. (GRWG)
NetworkNewsWire, Zacks, MarketBeat, Pot Stock News, Insider Financial, Wall Street Alerts, CannabisMarketCap, Micro Small Cap, New Cannabis Ventures, Stockwatch, TipRanks and Stockhouse reported previously on GrowGeneration Corp. (GRWG), and today we report on the Company, here at the QualityStocks Daily Newsletter.
GrowGeneration Corp. is the largest chain of specialty retail hydroponic and organic garden centers, with 24 locations serving commercial and home growers. Additionally, the Company operates an online superstore for cultivators, at HeavyGardens.com. GrowGeneration’s mission is to own and operate GrowGen branded stores in all the major legalized cannabis States in the U.S. and Canada. GrowGeneration is headquartered in Denver, Colorado.
GrowGeneration has 5 locations in Colorado, 5 locations in California, 2 locations in Nevada, 1 location in Washington, 4 locations in Michigan, 1 location in Rhode Island, 4 locations in Oklahoma,1 location in Oregon and 3 locations in Maine. The Company carries and sells thousands of products. These include organic nutrients and soils, advanced lighting technology and state-of-the-art hydroponic equipment to be used indoors and outdoors by commercial and home growers.
In 2019, GrowGeneration purchased the assets of GreenLife Garden Supply, with 2 locations in Maine and 1 location in New Hampshire. Following the acquisition, GrowGeneration now has 5 retail and warehouse locations serving the growing number of commercial cultivators in the New England market.
Yesterday, GrowGeneration reported record Revenue of $80 million for the 2019 fiscal year end. The Company had Revenue of $80.0 million, up $51.0 million or 176 percent in comparison to 2018. Revenue for Q4 2019 was $26 million in comparison to $9.1 million for Q4 2018.
Same Store Sales were up 62 percent for Q4 2019 versus Q4 2018. Same Store Sales were up 36 percent for fiscal year 2019 versus 2018. In addition, total new store and acquired stores for 2019 totaled 11 new store locations.
Furthermore, GrowGeneration is investing in opening new store locations in markets that include St. Louis, Kansas City, Phoenix, Miami, Los Angeles and Chicago. In addition to the new store openings, it is working on a number of acquisitions that are expected to close in the first part of this year.
Today, GrowGeneration announced that Chief Executive Officer, Mr. Darren Lampert. and President, Mr. Michael Salaman will speak at the ICR Conference 2020 on January 13, 2020 at 9:00 a.m. ET in Orlando, Florida.
GrowGeneration Corp. (GRWG), closed Thursday's trading session at $4.38, up 2.0979%, on 346,821 volume with 1,366 trades. The average volume for the last 3 months is 149,039 and the stock's 52-week low/high is $2.51999998/$5.75.
Lifeloc Technologies, Inc. (LCTC)
NetworkNewsWire, Promotion Stock Secrets, Infront Analytics, Market Exclusive, Stockhouse, Wallet Investor, Stockopedia, last10k, OTC Dynamics, Stockwatch, InvestorsHub, Dividend Investor, and Simply Wall St reported earlier on Lifeloc Technologies, Inc. (LCTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Lifeloc Technologies, Inc. is a worldwide leader in the development and manufacturing of breath alcohol and drug testing devices. It is a manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers. From its U.S. headquarters, the Company designs, engineers and manufactures precision, fuel cell based, breath alcohol testing equipment for professional and personal use. Lifeloc Technologies is based in Wheat Ridge, Colorado.
The Company offers a complete line of Portable Breath Alcohol Testers (PBTs) and Evidential Breath Testers (EBTs). Lifeloc is a single source for alcohol testing equipment, drug screening supplies, as well as education. Lifeloc offer a full range of models incorporating its patented alcohol detection and sensing algorithms and using its platinum fuel cell technology. The Company’s professional units are tested and approved by the National Highway Traffic Safety Administration (NHTSA), a part of the U.S. Department of Transportation (DOT), and numerous State forensic and international laboratories.
In the United States, Lifeloc supports its Workplace customers through a nationwide network of industry accredited and Lifeloc certified drug and alcohol training consultants. The Company assists organizations of all sizes in establishing and managing their drug and alcohol testing programs.
This past November, Lifeloc Technologies announced financial results for Q3 ended September 30, 2019. It posted quarterly Net Revenue of $2.258 million resulting in quarterly Net Income after taxes of $152 thousand, or $0.06 per diluted share. These results compare to Net Revenue of $2.056 million and quarterly Net Income of $58 thousand, or $0.02 per diluted share in Q3 of 2018.
The Company’s Q3 performance benefited from the release and shipments of the second generation of its patent protected EasyCal® automated calibration station, and also increased royalties. This updated calibration station has expanded capabilities to calibrate Lifeloc’s entire line of professional breathalyzers and RFID (Radio Frequency Identification) registration of calibration standards to further automate the process, representing a further advance of an already inventive product.
Lifeloc Technologies, Inc. (LCTC), closed Thursday's trading session at $5.45, up 21.1111%, on 2,073 volume with 19 trades. The average volume for the last 3 months is 165 and the stock's 52-week low/high is $3.50/$6.25.
BioRestorative Therapies, Inc. (BRTX)
Simply Wall St, Capital Cube, Pink Investing, Proactive Investors, 4-Traders, Market Screener, MarketWatch, InvestorsHub, Barchart, Stockopedia, ProActive Capital, GuruFocus, Investor Ideas, Corporate Information, Streetwise Reports, Zacks, Stockhouse, and Marketbeat reported previously on BioRestorative Therapies, Inc. (BRTX), and we also report on the Company, here at the QualityStocks Daily Newsletter.
BioRestorative Therapies, Inc. is a life sciences company focusing on adult stem cell-based therapies for various personal medical applications. The Company develops products and medical procedures utilizing cell and tissue protocols, primarily involving adult stem cells. OTCQB-listed, BioRestorative Therapies has its corporate, administrative, and laboratory operations in Melville, New York.
The Company’s aim is to become a leader in providing medical procedures using cell and tissue protocols, chiefly involving adult stem cells (non-embryonic), and enabling patients to undergo minimally invasive cellular-based treatments. BioRestorative Therapies is developing a cell-based therapy to target obesity and metabolic disorders utilizing brown adipose (fat) derived stem cells to produce brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans.
Bio Restorative’s lead cell therapy candidate is BRTX 100. This product is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. The Company’s products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and ThermoStem®, its Metabolic Program.
brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™’s intention is for patients who have failed non-invasive procedures and face the prospect of surgery. ThermoStem® is a treatment using brown fat stem cells. ThermoStem® is under development for metabolic disorders, including diabetes and obesity.
BioRestorative Therapies is also the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.
Recently, BioRestorative Therapies announced the creation of a Disc Advisory Committee of its Scientific Advisory Board (SAB). Jason Lipetz, MD, a member of the Company’s SAB headed by Dr. Wayne Marasco, will Chair the newly created Committee. Dr. Lipetz joined the SAB in October of 2018.
In addition to Wayne Olan MD, the Director of BioRestorative’s Disc/Spine Regenerative Program, the SAB added Harvinder Sandhu, MD; Christopher Plastaras, MD; and Gerard A. Malanga, MD.
Wayne Marasco, MD, Ph.D., Chairman of the BioRestorative Therapies Scientific Advisory Board, said, "Dr. Jason Lipetz has recruited a prestigious team of spine experts. This SAB subcommittee will provide outstanding leadership and guidance to BRTX as we move toward initiation of our clinical trial for our lead BRTX-100 autologous stem cell product.”
BioRestorative Therapies, Inc. (BRTX), closed Thursday's trading session at $0.0099, up 59.6774%, on 41,158,963 volume with 817 trades. The average volume for the last 3 months is 3,530,385 and the stock's 52-week low/high is $0.004199999/$0.910000026.
ProGreen US, Inc. (PGUS)
Amigo Bulls, InvestorsHub, Market Exclusive, Morningstar, Stockhouse, Marketwired, Uptick Newswire, Investors Hangout, Insider Financial, Penny Stock Prodigy, Promotion Stock Secrets, Barchart, MarketWatch, GuruFocus, and GlobeNewswire reported earlier on ProGreen US, Inc. (PGUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
ProGreen US, Inc. engages chiefly with investments in agricultural and real estate projects in Baja California, Mexico. The Company is concentrating on intensifying its property investments in Baja California, Mexico, through its joint venture (JV) partnership with Inmobiliaria Contel, and via its subsidiary Procon Baja JV. ProGreen US is based in San Diego, California.
Concerning ProGreen US’s Baja Project, the Company entered into a JV with a Mexican landowner, Inmobiliaria Contel and has jointly created Pro Baja. This is its newest JV with ProGreen owning 51 percent and Inmobiliaria Contel 49 percent. ProGreen US established an office location in Ensenada. This office serves as headquarters for all of its activities in Baja California. At present, Contel is active in the high margin produce industry, growing crops for exporters to the U.S. market, with an abundance of land available for expansion under its JV partnership.
Moreover, 5,100 acres of land was acquired by Procon Baja JV, with 4.7 miles of oceanfront on the Bay of El Rosario, for which a master plan is being drawn for the development of a very large, completely green, global vacation and retirement community named "CieloMar." ProGreen US completed development of the first tract of land, which comprises roughly 300 acres. Of this, some 100 usable acres were cleared.
ProGreen US previously signed another agreement for a further 1,900 acres (500-800 usable for farming), and a 3-year option for 11,500 acres (1000-2500 usable for farming). The land, once developed and prepared, will be offered for long term lease (10-15 years), with the JV holding the title.
ProGreen US previously announced that it's subsidiary, Procon Baja JV (Procon), closed on the purchase and took possession of the new 2,500-acre tract of land in Baja California. The total purchase price is $160,000 (USD).
ProGreen Farms™ Rancho Arenoso is growing chili peppers on the approximately 100 acres now undergoing farming. It has plans for diversifying the operation with other types of produce for U.S. buyers as it expands onto the close by 2,500 acres that ProGreen's Mexican subsidiary, Procon Baja JV, acquired in June of 2018.
Recently, ProGreen US, in combination with its subsidiary, Procon Baja JV, executed a joint venture (JV) alliance contract with real estate giant EXIT Corp International's most successful regional franchise owners of EXIT Southeast. Exit Southeast (EXIT) will coordinate U.S. operations and initiate strategic sales/marketing of Cielo Mar Baja California Resort Sales.
This deal will target and deploy EXIT's 11,000-plus agents, with an extensive database of buyers/investors to commence presales corporate wide, throughout their connected 800 offices in the U.S. and Canada. The Exclusive Contract with EXIT Realty starts March 1, 2019. It gives EXIT access to Cielo Mar’s 10,000-plus unit inventory of Single Family Homes and Multi-Family Condos over the course of the 4 1/2 mile, 5000 acre oceanfront development.
ProGreen US, Inc. (PGUS), closed Thursday's trading session at $0.0004, up 33.3333%, on 659,000 volume with 7 trades. The average volume for the last 3 months is 1,559,504 and the stock's 52-week low/high is $0.0003/$0.0034.
Micromem Technologies, Inc. (MMTIF)
MarketWatch, Penny Stock Tweets, Infront Analytics, Equity Clock, InvestorsHub, SmallCapVoice, Dividend Investor, last10k, Xtremepicks, OurHotStockPicks, GuruFocus, Wallet Investor, Stockhouse, Morningstar, Stock Stars, Trading View, PennyStocks24, Capital Cube, Investors Hangout, and Pink Investing reported earlier on Micromem Technologies, Inc. (MMTIF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Micromem Technologies, Inc. is a leader in viable Sensor Technology and MRAM (Magnetoresistive Random Access Memory). At present, the Company is focused on magnetic sensor applications via its wholly-owned subsidiary, Micromem Applied Sensor Technologies, Inc. (MAST, Inc.). OTCQB-listed, Micromem Technologies is based in Toronto, Ontario. The MAST, Inc. subsidiary is based in New York, New York.
Micromem’s technologies and solutions include surface functionalization of magnetic nanoparticles; nanoparticle detection platforms to sub-ppb detection levels; customized integration of NEMS/MEMS sensor platforms; magnetic sensor solutions; and sensor-based analytical solution platforms. Technologies and solutions also include structural integrity sensors; wireless suib-surface power solutions; asset protection sensor platforms; and energy storage solutions.
Micromem Technologies designs, develops and provides sensors specific to industry needs. The MAST subsidiary centers on developing and marketing the delivery of inventive magnetic sensor applications in industries including Defense, Life Sciences, Automotive, Consumer, and Mining. MAST develops MEMS/NEMS solutions through combining disparate sensor modalities to create solutions for clients’ problems.
MAST works closely with its clients during development to ensure a smooth transfer to their production facility. MAST is not a product company.
Concerning Energy Storage Solutions, MAST, working together with an energy storage company and a top U.S. utility, is providing sensor technology and overall system and product integration management for the practical realization of a new energy storage system. This system will enable lower costs than building new power generating plants.
Pertaining to its Magnetic Nanoparticle Detection Platform, MAST, working with a leader in the oil industry, has developed an instrument that detects breakthrough water in production oil wells through magnetic and optical sensor techniques.
Recently, Micromem Technologies, via Micromem Applied Sensor Technologies, Inc. (MAST), announced an update on the status of the ATRA 171 project it has been developing over the last 5 years with its oil company partner, Chevron Corporation (NYSE: CVX). With this agreement, the continuing pilot project is proceeding through on site well evaluation. Also, the commercialization plans for this technology are progressing.
Micromem Technologies, Inc. (MMTIF), closed Thursday's trading session at $0.03, up 30.4348%, on 9,701 volume with 6 trades. The average volume for the last 3 months is 602,142 and the stock's 52-week low/high is $0.010499999/$0.085.
Kiwa Bio-Tech Products Group Corporation (KWBT)
Lions of Wall Street, Fast Moving Stocks, Darth Trader, Wallstreetlivechat, OTC Picks, Penny Stock Rumble, StockMister, The Penny Play, Equities, SmallCapVoice, The Stock Psycho, and Top Gun reported previously on Kiwa Bio-Tech Products Group Corporation (KWBT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Kiwa Bio-Tech Products Group Corporation is a manufacturer concentrating on eco-friendly bio-based fertilizers promoting soil health. The Company develops, manufactures, distributes, and markets novel, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation. Organic, ecologically sound, and "green" practices are its theme. Kiwa Bio-Tech Products Group has its corporate office in Claremont, California.
Kiwa Bio-Tech’s commitment is to making safe food, further developing eco-agriculture, and upholding a responsibility of contributing to China's agricultural safety, food safety, and a healthy lifestyle. The Company’s dedication is to eco-agricultural development and environmental control through developing, producing, and selling bio-technological products with high technology, low-cost, and high productivity to satisfy rising market demand.
The design of its products is to enhance the quality of human life through boosting the value, quality, and productivity of crops and lessening the negative environmental impact of chemicals and other wastes. The Company utilizes new bio-technological skills at its core. Its new products structure includes 16 kinds of products in 5 major categories - Biological Organic Fertilizer, Compound Microorganism Fertilizer, Microorganism Bacterium Agent, Biological Soluble Fertilizer, and Organic-Inorganic Compound Fertilizer.
Kiwa Bio-Tech launched a joint venture (JV) with Zhongshi'an Agricultural Science & Technology Co., Ltd. and Xintaitianyi Financial Service and Science & Technology Co., Ltd. The name of the JV is Inner Mongolia Jingnong Investment Management Co. Ltd. Also, Kiwa Bio-Tech has established retail outlet stores in Shaanxi Province that distribute its fertilizer products.
Presently, the Government of China is providing significant financial support and is strongly promoting the integration of farming and breeding programs in rural areas. Kiwa Bio-Tech is presently in a lead position to provide eco-friendly planting techniques and fertilizer utilization methods that will contribute to the development of the program.
Additionally, the Company anticipates enhancing local farmers’ income. Kiwa Bio-Tech received approval from the Yangling Free Trade Zone in China to obtain land for the construction of a manufacturing facility to meet the US$16 billion-dollar increasing demand for bio-fertilizers in China over the next 5 years.
Kiwa Bio-Tech Products Group Corporation (KWBT), closed Thursday's trading session at $0.0245, up 32.4324%, on 27,064,744 volume with 682 trades. The average volume for the last 3 months is 3,571,952 and the stock's 52-week low/high is $0.0175/$1.45000004.
Acura Pharmaceuticals, Inc. (ACUR)
CRWEWallStreet, PennyToBuck, StreetInsider, Marketbeat, SmarTrend Newsletters, Wall Street Resources, PennyOmega, PennyStocks24, Penny Stock Rumble, The Street, BestOtc, BUYINS.NET, CRWEFinance, StockHotTips, and DrStockPick reported on Acura Pharmaceuticals, Inc. (ACUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company innovating abuse deterrent drugs. It engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse, utilizing its proprietary LIMITx™, AVERSION®, and IMPEDE® Technologies. OTCQB-listed, Acura Pharmaceuticals is based in Palatine, Illinois.
The patented LIMITx technology works by neutralizing stomach acid with buffering ingredients as increasing numbers of tablets are swallowed. It relies on stomach acid to play a role in the release and subsequent systemic absorption of the active ingredient from micro-particles contained in the tablets.
The intention of the LIMITX™ Technology is to address an oral Excessive Tablet Abuse (ETA) or accidental consumption of multiple tablets and provide a margin of safety during accidental over-ingestion of tablets. Additionally, LIMITX™ is expected to exhibit barriers to abuse by snorting and injection. LTX-04 is Acura’s lead development candidate employing its novel LIMITx™ technology.
AVERSION® Technology is a patented composition of commonly used active and inactive pharmaceutical ingredients providing abuse deterrent features and benefits for orally administered pharmaceutical drug products. The intention of AVERSION® Technology opioid analgesic product candidates is to provide effective relief from pain. This is while discouraging common methods of pharmaceutical product misuse and abuse.
OXAYDO® (oxycodone HCl immediate-release tablets), which incorporate the AVERSION Technology, is Food and Drug Administration (FDA) approved and marketed in the United States by Acura’s partner Egalet Corp.
The IMPEDE® Technology platform is an advanced polymer matrix. It is used in NEXAFED®, Acura Pharmaceuticals’ pseudoephedrine (PSE) tablet product, to limit or disrupt the extraction of PSE from tablets for conversion into the illicit drug methamphetamine.
NEXAFED® and NEXAFED® Sinus are pseudoephedrine containing products that use the IMPEDE Technology. They are marketed in the United States by Acura Pharmaceuticals’ partner MainPointe Pharmaceuticals.
Recently, Acura Pharmaceuticals announced financial results for the three and six months ended June 30, 2018. Acura reported a Net Loss of $2.8 million or $0.13 per diluted share for the six months ended June 30, 2018, versus a Net Loss of $1.7 million or $0.15 per diluted share for the same period in 2017. For the Q2 2018, it reported a Net Loss of $1.3 million or $0.06 per diluted share versus a Net Loss of $2.2 million or $0.18 per diluted share for the same period in 2017.
Acura Pharmaceuticals, Inc. (ACUR), closed Thursday's trading session at $0.32, up 32.7801%, on 8,300 volume with 5 trades. The average volume for the last 3 months is 9,938 and the stock's 52-week low/high is $0.109999999/$0.629999995.
Protalex, Inc. (PRTX)
StreetInsider, Zacks, TopStockAnalysts, and OTCPicks reported on Protalex, Inc. (PRTX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Protalex, Inc. is a clinical-stage Biopharmaceutical Company based in Florham Park, New Jersey. Its emphasis is on the development of a class of drugs for treating autoimmune and inflammatory diseases. These include RA (Rheumatoid Arthritis) and ITP (Immune Thrombocytopenia). The Company’s lead product is PRTX-100. This is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria. Protalex’s shares trade on the OTC Markets Group’s OTCQB.
Rheumatoid arthritis (RA) is an autoimmune disease. RA is a disorder in which the body’s immune system mistakenly attacks the joints. Immune Thrombocytopenia (ITP) is a blood disorder. ITP can result in easy or excessive bleeding and bruising because of the body’s inability to form blood clots.
Pre-clinical data indicate that PRTX-100 may have the potential to treat ITP through reducing the immune-mediated destruction of the platelets. Protalex has open IND’s for the treatment of RA and ITP in the United States, and in Europe, an open IMPD for ITP.
Protalex’s PRTX-100 can (at very low concentrations) bind to human B-lymphocytes and macrophages and to modulate immune processes. PRTX-100 has been granted Orphan Drug Designation in the United States and in Europe for the treatment of ITP. This status provides commercial exclusivity benefits, tax credits for certain research, potential research grants and a waiver of the New Drug Application user fee in the United States. Currently, it is the subject of clinical studies in the U.S. and Europe.
PRTX-100 is administered as a short intravenous infusion. The following patents have been granted for PRTX-100: U.S. Patent No. 9,370,552 (‘552 patent) is a continuation patent to initial U.S. patent No. 7,211,258 (Protein A compositions and methods of use) filed in 2002 and issued with method of treatment claims for RA, juvenile RA, and systemic lupus erythematosus (SLE). The ‘552 patent expands the method of treatment of PRTX-100 to include type 1 diabetes.
European Patents No. 2,570,136 and 2,206,511 (national patents in place in France, Germany, Italy, Spain, Switzerland, and the UK) includes composition claims relating to numerous autoimmune diseases (RA, ITP, juvenile RA, psoriasis, myasthenia gravis) and dosage expansion.
Canadian patents No. 2,894,098 and No. 2,481,282 comprise method of treatment claims relating to RA and SLE. Japanese patent No. 5,523,796 claims compositions for treating psoriasis, scleroderma, Crohn’s Disease, myasthenia gravis, ulcerative colitis, psoriatic arthritis, as well as pemphigus vulgaris.
Recently, Protalex announced that following a planned interim analysis of data from the fourth dose cohort of its European Phase 1b study of PRTX-100 (PRTX-100-203 Study) in adults with persistent/chronic Immune Thrombocytopenia (ITP), it initiated enrollment in the fifth and highest dose cohort of this dose-escalating study.
The first patient in the final cohort was recently dosed in the United Kingdom at 24 micrograms/kg. This the highest dose of PRTX-100 used in any clinical trial to date. One of the three patients treated in the fourth dose cohort (18 micrograms/kg) attained a protocol defined platelet response.
Protalex, Inc. (PRTX), closed Thursday's trading session at $0.015, up 114.2857%, on 96,377 volume with 20 trades. The average volume for the last 3 months is 7,833 and the stock's 52-week low/high is $0.0015/$0.189999997.
Sunvalley Solar, Inc. (SSOL)
Wallstreetlivechat, PennyStockPros, The Stock Scout, Penny Stock Rumble, Stockhunter.us, PennyStockClub, OurHotStockPicks, PennyStocks24, Fast Moving Stocks, VIP STOCK ALERTS, and FeedBlitz reported previously on Sunvalley Solar, Inc. (SSOL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Sunvalley Solar, Inc., by way of its subsidiary, Sunvalley Solar Tech, Inc., operates as a solar power technology and system integration company in the State of California. The Company centers on solar systems design and installation, solar technology research and development (R&D), and solar equipment manufacturing and distribution areas. Established in 2007, Sunvalley Solar is headquartered in in Walnut, California.
Sunvalley Solar acquired Rayco Energy, Inc. in 2016. Rayco Energy is an established northern California company. It specializes in providing cost-saving and efficient energy solutions to local communities and business units. This includes LED lighting, Solar Thermal, as well as Solar Electricity.
Rayco Energy combines energy efficiency measures with renewable energy sources. It services the multi-family sector (Apartments, Homeowner Associations (HOA)) and small-sized commercial projects.
Sunvalley Solar’s business development strategy is to develop the Company as the end-to-end solar energy solution provider for solar power equipment dealers, solar power system installers, and solar power energy end users.
The Company provides turnkey solar system solutions. These include designing, building, operating, monitoring, and maintaining solar power systems for owners, builders, and architecture firms. Its R&D team comprises PhDs in Optoelectronics. The team specializes in photovoltaic panel technologies (coating and focusing).
In addition, the Company’s focus is in the area of National Solar Technical Support and a Service Center. Sunvalley Solar serves small private residences and large commercial solar power users.
The Company’s R&D team’s projects include 975 kW commercial solar power systems for distribution warehouses and manufacturing companies. Furthermore, projects include 1 MW commercial solar power systems for agriculture farms and cold storage facilities.
Its R&D is presently focusing on developing new coating technology to increase the efficiency of PV panels; developing new focusing technology to reduce the size of silicon cells and reduce the silicon cost per watt; developing solar PV application technology to decrease system level cost; and developing new solar parts – Micro-inverters.
Sunvalley Solar has its patented technology – Networked Solar Panels and Related Methods. It has patented the technology "Networked Solar Panels and Related Methods" (USPTO 12/198,076). This technology enables the solar power system operator to monitor the grid status, and manage and control the output from each panel, each subsystem, and the system as a whole.
Sunvalley Solar, Inc. (SSOL), closed Thursday's trading session at $0.028, up 101.4389%, on 592 volume with 8 trades. The average volume for the last 3 months is 1,360 and the stock's 52-week low/high is $0.012699999/$0.052499998.
The QualityStocks Company Corner
- SRAX Inc. (NASDAQ: SRAX)
- Sigma Labs Inc. (NASDAQ: SGLB)
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)
- Pressure BioSciences Inc. (PBIO)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- MCTC Holdings Inc. (OTC: MCTC)
- Sharing Services Global Corporation (SHRG)
- SinglePoint, Inc. (SING)
- Green Hygienics Holdings Inc. (OTCQB: GRYN)
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
SRAX Inc. (NASDAQ: SRAX)
Consumer data is emerging as individuals’ “most ignored and valuable asset,” yet emerging privacy concerns give consumers legitimate pause when it comes to reaping data’s benefits (http://nnw.fm/X61Sp). SRAX Inc. (NASDAQ: SRAX) is on the forefront of these industry trends due to its diligence in protecting consumers while simultaneously empowering them to benefit from their data. While offering consumers unique technology and tools to safely approve and monetize their personal data, access is then sold to marketers that benefit from accurate consumer information and opinions. SRAX accomplishes all of this through its patented BIGtoken platform, which provides compensation to users who provide consumer data.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Thursday's trading session at $2.5558, up 6.9372%, on 105,754 volume with 300 trades. The average volume for the last 3 months is 126,171 and the stock's 52-week low/high is $1.04999995/$5.8499999.
- SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Both Empowers and Protects Consumers with Growing Data Privacy Concerns
- SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Mobile App Collects Accurate Information, Allows Users to Unlock Value of Data
- CCPA is Effective and Most Companies Are Not Compliant
Sigma Labs Inc. (NASDAQ: SGLB)
Sigma Labs (NASDAQ: SGLB) is the developer behind the innovative PrintRite3D(R) software, a proprietary, real-time, computer-aided inspection (‘CAI’) technology that enables real-time, in-process, quality assurance. To view the full article, visit http://nnw.fm/uGKC8
Software companies can prove to be exceptionally lucrative and rewarding when they provide critical solutions to complex problems. Sigma Labs Inc. (NASDAQ: SGLB) is in just such an enviable position. The company is the recognized pioneer in the development and commercialization of real-time, computer-aided inspection solutions for the 3D metal printing industry.
Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.
For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.
Revolutionizing Additive Manufacturing
Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.
Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.
Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.
Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.
Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.
Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.
Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.
Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.
Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.
John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.
Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.
CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.
Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.
Sigma Labs Inc. (SGLB), closed Thursday's trading session at $1.005, up 0.50%, on 69,428 volume with 121 trades. The average volume for the last 3 months is 194,698 and the stock's 52-week low/high is $0.451099991/$2.46000003.
- Sigma Labs Inc. (NASDAQ: SGLB) Recognized for Creating Most Innovative Quality-Assurance Software for 3D Printing Industry
- Sigma Labs Inc. (NASDAQ: SGLB) to Help Aerospace Manufacturers Overcome 3D Quality Manufacturing Problems
- Sigma Labs Inc. (NASDAQ: SGLB) Provides Disruptive In-Process, QA Software for Commercial 3D Metal-Printing Industry
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Oral drug product innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is well situated to take advantage of the market arising from Canada’s sweeping legal changes, as well as the burgeoning market for infused edibles in select states within the United States. Canada’s regulatory innovations in making cannabis products accessible nationwide for both therapeutic and recreational purposes have led to this year’s ‘Cannabis 2.0’ national rollout of laws for a new edible cannabis-infused market. Also today, the company announces a strategic update. For the full version, please go to www.lexariabioscience.com/news/
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.425, up 28.7879%, on 459,635 volume with 178 trades. The average volume for the last 3 months is 101,546 and the stock's 52-week low/high is $0.3037/$1.6875.
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Holds Key Position as Edible Cannabis Market Opens Wide
- Lexaria Provides Strategic Update from CEO
- Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Patented DehydraTECH™ Platform Increases CBD Tissue Absorption by 1,937%
Pressure BioSciences Inc. (PBIO)
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries, today announced that in 2019 - for the second straight year - over 20 scientific papers highlighting the advantages of PBI's patented pressure cycling technology ("PCT") platform were published worldwide. To view the full press release, visit http://nnw.fm/HHaY7.
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed Thursday's trading session at $0.948, even for the day, on 12,020 volume with 11 trades. The average volume for the last 3 months is 12,780 and the stock's 52-week low/high is $0.600600004/$4.0300002.
- Pressure BioSciences, Inc. (PBIO) Announces Second Straight Year of Strong Publication Numbers of Scientific Papers Citing Advantages of its PCT Platform
- Zacks Maintains Strong $4.44 Price Target for Pressure BioSciences Inc. (PBIO)
- Zacks Small Cap Research Releases Updated Report on Pressure BioSciences, Inc.
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) 7ACRES cultivation facility Tour Video released! http://www.newsfilecorp.com/redirect/0A8JievZ. With construction on the 440,000 sq.ft. 7ACRES facility nearly complete, Supreme Cannabis is positioned to realize the full potential of this flagship asset. The company has built out its CPG processing features, and all grow rooms are coming online - Supreme Cannabis is now positioned to execute on its CPG strategy, leaving its wholesale business behind to capture greater margins from 100% consumer sales.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.
A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.
Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.
In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:
- Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
- Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
- Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
- Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.
Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:
- Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
- Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
- Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
- R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.
Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $0.39, even for the day, on 356,926 volume with 239 trades. The average volume for the last 3 months is 513,468 and the stock's 52-week low/high is $0.361999988/$1.7888.
- 7ACRES Tour Video - Understanding Supreme's Premium Advantage
- Indiva Ships Sugarleaf by 7AC Pre-Rolls Nationwide
- Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Leadership Transition to Accelerate Growth into Premium Cannabis CPG Company
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) was featured today in a report by NetworkNewsWire. Streaming is a highly lucrative segment fueled by the demand to control one’s own entertainment, which gave rise to the VCR back in the 1970s. The media has dubbed this pronounced entertainment conflict the ‘streaming wars’. The race to capture content streaming consumers is a key feature of modern-day entertainment, as shown during a broadcast (http://nnw.fm/IrQq9) titled ‘Filmmakers Poised for Big Gains in Hollywood’s Streaming Wars’.
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.
Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.
Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.
The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.
Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.
Management Team with Proven Track Records
Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.
Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.
Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.
Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.
Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.
17-Title Movie Slate — Greenlit
Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.
Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.
The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.
Potential for Breakout Success
Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.
Note: Potential breakout films are not factored into company’s revenue projections.
Base Hits and Home Runs
In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.
Recent Industry Breakout Films Include:
- SAW – $1.2 million budget = $103.9 million in sales
- Pulp Fiction – $8 million budget = $212 million in sales
- My Big Fat Greek Wedding – $5 million budget = $250 million in sales
- Lost in Translation – $4 million budget = $120 million in sales
- Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)
Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.
Recent Wonderfilm Releases
- Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
- Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
- Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
- Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.
Wonderfilm Global Distribution
At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.
Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.
The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.
A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.
Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.
Wonderfilm Business Model
Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.
Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.
Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.
Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.
Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.
Sales overages once contracted presale threshold is surpassed.
The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.
Note: The nature of the film business is that box office revenue lags production up to a couple of years.
$50 Million Wonderfilm Production Fund (WPF):
Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.
The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.
For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.
All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.
Wonderfilm Media Corporation (OTC: WDRFF), closed Thursday's trading session at $0.106, even for the day, on 2,500 volume. The average volume for the last 3 months is 59,801 and the stock's 52-week low/high is $0.072099998/$0.443650007.
- Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Leveraging Business Model, Content Production to Profit from Growing Demand
- SVoD Market Opening its Doors to Low-Cost Film Content Creators Such as Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF)
- Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Capitalizing on Growing Demand for High-Quality Content
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands (CSE: GGB) (OTCQB: GGBXF)this morning announced that Chief Marketing Officer (“CMO”) Jann Parish will be speaking at NRF 2020 Vision: Retail's Big Show in New York City which is taking place January 12-14, 2020. To view the full press release, visit http://cnw.fm/8kAQP.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $0.554, off by 4.3508%, on 156,148 volume with 139 trades. The average volume for the last 3 months is 276,577 and the stock's 52-week low/high is $0.469999998/$5.20499992.
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) CMO to Participate in Panel Discussion at Upcoming Retail Industry Event
- 420 with CNW – Virginia Governor Wants Marijuana Decriminalized in the State in 2020
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Leverages Retail, Operations Expertise to Capitalize on Holiday Shopping Season
MCTC Holdings Inc. (OTC: MCTC)
MCTC Holdings Inc. (OTC: MCTC) was featured today in a publication from CBDWire, examining how the cannabidiol (CBD) sector has probably given regulatory authorities a ton of headaches. Only a year old, the industry is now worth millions in sales, and experts predict it could hit $20 billion by 2026. The chemical is extracted from hemp, a variety of cannabis that has minuscule levels of THC, a chemical that makes marijuana users high. The plant was outlawed for decades, and it was only the 2018 Farm Bill that freed it from prohibition and allowed farmers to grow the crop.
MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.
With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).
MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.
The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):
- Significantly improving bioavailability
- Allowing for ultra-high loading rates
- Enhancing customization of cannabinoid combinations
- Improved dosing precision
- Providing more control in release parameters
MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.
MCTC has now filed four patents on its cannabinoid delivery technology systems:
- The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
- Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
- Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
- Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.
MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).
MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.
MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.
MCTC Holdings Inc. (MCTC), closed Thursday's trading session at $0.32, off by 5.8824%, on 204 volume with 3 trades. The average volume for the last 3 months is 10,868 and the stock's 52-week low/high is $0.075000002/$3.00.
- Sellers Say Newly Enacted CBD Law in New York is Good for Customers
- Iowa Ag Department Starts Receiving Comments on Its Proposed Hemp Program
- MCTC Holdings Inc. (MCTC) CEO Discusses Development of Hemp-Related Products and Delivery Technologies in Exclusive Interview
Sharing Services Global Corporation (SHRG)
Following shifts in the direct-selling community during 2019, Sharing Services Global Corporation (OTCQB: SHRG) is prepared to face both the challenges and opportunities presented in the new year. To view the full article, visit http://nnw.fm/Cy5OL. Also today, NetworkNewsWire released a report on the company detailing how, in SHRG’s 10-Q filed with the SEC for the three months ended October 31, 2019, reported sales of $38,850,483 for Q2 2019, or 116% greater than the $17,973,379 SHRG reported for the comparable quarter last year (http://nnw.fm/qV6ke). Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.0989, off by 1.10%, on 3,000 volume with 3 trades. The average volume for the last 3 months is 27,860 and the stock's 52-week low/high is $0.065800003/$0.3944.
- Sharing Services Global Corporation (SHRG) Poised to Tackle Shifting Direct-Selling Industry
- Sharing Services Global Corporation’s (SHRG) Q2 Revenues More Than Double Last Year’s Comparable Period Due to Effective Strategies
- Sharing Services Global Corporation (SHRG) Continues to Post Record Sales; Forecasts Continued Success Moving into New Year
SinglePoint, Inc. (SING)
SinglePoint (OTCQB: SING) today released an audio update from its CEO sharing his vision for the company. To view the full press release, visit http://cnw.fm/Gi8K7. Also today, the company was highlighted in a publication from HempWireNews, examining how Hemp is one of the most useful plants you’ll find out there. Most plants can only be used in a few ways, but hemp’s applications are said to be in the thousands. Hemp can be used to make fabric, bioplastic, and hempcrete, a building material made from a mixture of hemp wood pulp, water, and lime. On top of that, hemp seeds have great nutritional value.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Thursday's trading session at $0.00838, off by 5.4176%, on 4,022,332 volume with 124 trades. The average volume for the last 3 months is 3,277,599 and the stock's 52-week low/high is $0.007/$0.023499999.
- SinglePoint, Inc. (SING) CEO Shares Exciting 2020 Vision via Audio Release
- 2020 Annual Asia Hemp Summit Speakers Revealed
- SinglePoint Inc. (SING) Finalizes Distribution Agreement, Debuts Premium Tobacco Product at World’s Largest Gathering of Cannabis Professionals
Green Hygienics Holdings Inc. (OTC: GRYN)
Green Hygienics Holdings (OTCQB: GRYN), an innovative, premium-cannabis cultivation and branding enterprise, recently appointed seasoned business executive Sid Senroy as the new head of quality and compliance. To view the full article, visit http://cnw.fm/q2lXS.
Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol (CBD). With more than 25 years of experience in agricultural science and innovation, Green Hygienics aims to become one of the largest providers of industrial hemp-derived CBD products on the planet.
Green Hygienics’ business model includes generating revenues from the sale of hemp and premium-grade CBD products, creating trusted global consumer brands, developing valuable intellectual property (IP) and growing rapidly through strategic acquisitions. With direct regard to acquisitions, the company acts as a business accelerator and a vertical integrator supporting rapid growth and development of companies with extraordinary potential.
Innovation – the Future of Commercial Cultivation
The greatest challenge of the cannabis industry is determining how to deliver a safe and premium-quality product on a consistent basis; antiquated production methods are riddled with recalls and are unsafe from a cultivation production standpoint. Green Hygienics’ solution is to employ scientific methodology combined with sustainable farm practices to achieve optimal soil refinement. The company’s objectives are to produce higher yields and a superior product on a consistent basis to always remain compliant through diligent testing. A secure, premium-quality supply chain is the foundation for the company’s operations.
Green Hygienics’ cultivation approach is based on scientific measurements and data analysis, which transform the cultivation environment into a laboratory environment to deliver superior product.
Processing hemp to produce the finest-quality CBD is a complex, multistage process that should be performed with adherence to the highest standards. Once harvested, the hemp must be carefully handled, dried and stored to prepare it for CBD extraction. Each and every step must be given full care and attention. Green Hygienics’ ambition is to create state-of-the-art infrastructure, employ the latest large-scale processing technologies and adhere to strict quality management systems.
The company strives to constantly develop innovations in industrial hemp for CBD cultivation and to create solutions that lower costs, deliver higher yields and address the challenges of large-scale production.
Brand Development, Marketing and Direct Sales
One of the core drivers of the Green Hygienics business model is to develop or acquire unique brands with global distribution potential. The company sees the market becoming increasingly competitive, and establishing Green Hygienics’ own distinct, trusted brands will be important. By controlling its own supply chain, the company can also leverage strategic advantages in the marketplace, such as the ability to deliver a “best in class” product on a consistent basis. Successful branding is demonstrated by a positive response to a company’s customer service, reputation and products, and Green Hygienics Holdings is acutely aware of the value in this.
Ahead of the Curve
The clear competitive advantage Green Hygienics holds over industry peers is cultivating premium product within the upper-scale product category more efficiently than anyone else in the industry. Currently, the average-size hemp farm in North America is 9 acres. Green Hygienics addresses the challenge of scalability through its farming methodology.
The company’s objective is to produce a higher quality of product at a lower cost and to deliver the finest-quality product to consumers without exception.
In today’s market, inefficient companies and those that produce an inferior product will become vulnerable or disappear, adding considerable value to companies like Green Hygienics that efficiently innovate and operate. The premium cannabis market will continue to achieve higher pricing, and the demand will stabilize. At the end of the day, successful branding backed by superior product will cause companies like Green Hygienics to rise above the competition.
Companies within the cannabis sector, states and lawmakers are still figuring out how legislation, consumer demand and innovations will shape the industry. As a safeguard and for long-term resilience, Green Hygienics is preparing for the next plateau with proprietary cultivation and processing systems and tightly controlled growth environments that enable containment of production costs, delivery of higher yields and production of a premium product. These margins will provide the company with a strategic advantage within an increasingly competitive marketplace.
Green Hygienics is constantly studying the market dynamics in North America and abroad and anticipates that both the domestic and international markets will appreciate and be willing to pay a premium to those companies that can deliver best-in-class products.
In line with this expectation, the company’s additional objectives are to secure investment, enhance its balance sheet and increase its value through profitable operations as well as through acquiring and owning the real estate or land it builds upon. Over the long term, this will help Green Hygienics grow in value, provide leverage for rapid expansion and offer security for investors. The company will be positioned to capitalize on any opportunity within the industry or to acquire distressed assets, which is part of its growth strategy.
Green Hygienics plans to establish lead brands starting in the California market, to secure trademarks, and to develop and secure intellectual property assets with regard to cultivation and processing.
Green Hygienics Holdings Inc. (GRYN), closed Thursday's trading session at $2.002, up 0.603015%, on 7,795 volume with 8 trades. The average volume for the last 3 months is 9,355 and the stock's 52-week low/high is $0.224999994/$2.48000001.
- Green Hygienics Holdings Inc. (GRYN) Prepares for Increased Regulation by Appointing New Head of Quality, Compliance
- 5 Problems Farmers Identify in the USDA Hemp Rules
- Green Hygienics Holdings Inc. (GRYN) Appoints Sid Senroy to Head Quality Control in Recognition of Critical Industry Need for Compliance
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality ("AR") interactive entertainment games, toys and educational materials in China, today announced that its AR child abuse prevention course will be introduced in 25 preschools in Tong'an District, Xiamen City. To view the full press release, visit http://nnw.fm/2Feae.
Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.
Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.
Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.
Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.
The company has multiple products in development including new generations of four primary product lines and two new product lines.
Patents and Copyrights
Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.
Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.
Sales and Marketing
There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.
In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.
Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.
Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.
Blue Hat Interactive Entertainment Technology (BHAT), closed Thursday's trading session at $2.10, up 2.9412%, on 7,071 volume with 755 trades. The average volume for the last 3 months is 96,590 and the stock's 52-week low/high is $2.00999999/$6.25.
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Launches AR Child Abuse Prevention Course in 25 Preschools
- Blue Hat Interactive Entertainment Technology Announces Receipt of Delinquency Notification Letter from Nasdaq
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Non-Binding LOI to Acquire Controlling Equity Interest in Fuzhou Csfctech Co., Ltd.
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured today in a publication from HempWireNews, examining how the upcoming Asian Hemp Summit brings together hemp stakeholders from around the world to discuss industry concerns, and this year’s summit will be held on Jan 31- Feb 1 in Kathmandu, Nepal. Entrepreneurs, politicians, development agencies, researchers, environmental groups, retailers and private hemp enthusiasts will gather at the summit to explore the potential of Asian countries in hemp production.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Thursday's trading session at $0.959, up 3.5671%, on 54,559 volume with 182 trades. The average volume for the last 3 months is 131,107 and the stock's 52-week low/high is $0.779999971/$4.7800002.
- 2020 Annual Asia Hemp Summit Speakers Revealed
- Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) BioLumic Receives Approval to Apply Proprietary UV Light Technology to Medical Cannabis
- 420 with CNW – 5 Mistakes Commercial Cannabis Producers Should Avoid
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, this morning announced modifications made to restructure its leadership. TGODF president Csaba Reider will be leaving the organization, and his duties will be taken over by TGODF CEO Brian Athaide. To view the full press release, visit http://cnw.fm/4mjPt. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Marijuana consumers can attest to the fact that the modern marijuana experience is changing at lightning speed since they are experiencing the speedy growth firsthand. This is seen from the increased marijuana products being displayed on the shelves in dispensaries and the spread of marijuana reforms throughout the U.S. states, as well as the establishment of consumption lounges in selected locations. Besides, people should expect more changes in the marijuana sector in the near future.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $0.5254, up 3.5271%, on 1,041,072 volume with 357 trades. The average volume for the last 3 months is 1,389,317 and the stock's 52-week low/high is $0.469300001/$4.38000011.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Restructures Executive Leadership Team
- 420 with CNW – 3 Marijuana Trends Likely to Manifest in 2020
- The 7 Fastest-Growing Marijuana Stocks in 2020
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Expands B2 Fighting Series Official Training Facility Program with Acquisition of ONE More Gym
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Receipt of Delinquency Notification Letter from Nasdaq
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Top Italian Court Rules That Growing a Few Marijuana Plants at Home is Legal
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) BioLumic Receives Approval to Apply Proprietary UV Light Technology to Medical Cannabis
- ChineseInvestors.com (CIIX) Offers Powerful Two-Pronged Strategy for Investors, Shows Promise in China’s Emerging CBD Sector
- City View Green (CSE: CVGR) (OTC: CVGRF) Completes First Tranche Closing of Private Placement
- CloudCommerce (OTCQB: CLWD) SEC Qualifies CloudCommerce Reg A+ Public Offering
- Dama Financial - Product Integration With PayWana Set to Revolutionize Retail Checkout Processing
- Endonovo Therapeutics (OTCQB: ENDV) Announces Issuance of U.S. Patent, Expansion of its SofPulse(R) Intellectual Property Portfolio
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Significant New Advanced Features for QuadSight(R) Vision System
- Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Biotech Showcase(TM) 2020 in San Francisco
- GP Solutions (GWPD) GrowPods May Help Reduce Foodborne Illnesses
- Grapefruit Boulevard Investments Inc. (IGNG) Sellers Say Newly Enacted CBD Law in New York is Good for Customers
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) 420 with CNW – Virginia Governor Wants Marijuana Decriminalized in the State in 2020
- Green Hygienics Holdings Inc. (OTC: GRYN) 5 Problems Farmers Identify in the USDA Hemp Rules
- Hemptown USA - Unveils New CBG-Based Product Line at MJBizCon 2019; Reports 2019 Harvest Results
- HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Pennsylvania Farm Show Highlights Hemp in Unique Ways
- InsuraGuest, Inc. Launches IG Agency in Continued Expansion of InsurTech Platform and Product Offerings
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) 420 with CNW – Virginia Governor Wants Marijuana Decriminalized in the State in 2020
- Jerrick Media Holdings, Inc. (JMDA) CEO Details Big Payoff to Early Sacrifices, Organization Prepared for Endurance in Weekly Update
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Patented DehydraTECH™ Platform Increases CBD Tissue Absorption by 1,937%
- LiveWire Ergogenics Inc. (OTC: LVVV) Absence of Federal Regulations Exposes CBD Industry to Class Action Lawsuits
- Marijuana Company of America Inc. (MCOA) hempSMART Appoints Global Marketing and Sales Manager
- MCTC Holdings Inc. (MCTC) Iowa Ag Department Starts Receiving Comments on Its Proposed Hemp Program
- Neutra Corp. (OTCQB: NTRR) 420 with CNW – 5 Mistakes Commercial Cannabis Producers Should Avoid
- No Borders Inc. (OTC: NBDR) Young Lady Launches CBD-Infused Gin Inspired by Trip to India
- Nightfood, Inc. (OTCQB: NGTF) Announces Plans to Exhibit at 44th Annual Hotel, Motel & Restaurant Supply Show of the Southeast
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) to Report First Quarter Fiscal 2020 Results on January 14th, 2020 and Operational Update
- ORHub Inc. (ORHB) Announces Changes to Board of Directors, Management
- OriginClear (OCLN) CEO Emphasizes Significant Versatility of Water-Treatment Technology
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Updates Shareholders on Progress Achieved During 2019, Strategic Goals for 2020
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Closing of Financing, Production Increases at the Existing Facility to Reach Profitability and Expansion Plans for New 3,000 Barrel Facility
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) CEO and Co-Founder to Present Live at VirtualInvestorConferences.com
- Predictive Oncology Inc. (NASDAQ: POAI) Announces Appointment of Pam Prior to its Board of Directors
- Pressure BioSciences Inc. (PBIO) Zacks Maintains Strong $4.44 Price Target
- Quest Patent Research Corp. (QPRC) Court Denies Transfer Motion in Quest Patent Research Corp. (QPRC) Subsidiary’s Patent Litigation against Apple
- Sharing Services Global Corporation (SHRG) Continues to Post Record Sales; Forecasts Continued Success Moving into New Year
- Sigma Labs, Inc. (NASDAQ: SGLB) to Help Aerospace Manufacturers Overcome 3D Quality Manufacturing Problems
- SinglePoint, Inc. (SING) Finalizes Distribution Agreement, Debuts Premium Tobacco Product at World’s Largest Gathering of Cannabis Professionals
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Strategic Appointment of Jason DePue as US VP Sales
- Spectrum Global Solutions, Inc. (SGSI) Q3 2019 Financial Report Reveals Stronger Balance Sheet, Larger Portfolio
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Top Italian Court Rules That Growing a Few Marijuana Plants at Home is Legal
- SRAX Inc. (NASDAQ: SRAX) BIGtoken Mobile App Collects Accurate Information, Allows Users to Unlock Value of Data
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Unlocking the Value of Direct Lithium Extraction Resources in Alberta’s Oil Fields
- Sugarmade, Inc. (SGMD) 5 in 10 Wisconsin Banks Likely to Offer Services to Hemp Businesses in 2020
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Research Shows CBD Can Help Combat Social Anxiety Disorder Symptoms
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) The 7 Fastest-Growing Marijuana Stocks in 2020
- Trxade Group Inc. (TRXD) Reports Consistent Revenue Growth Trend, Plans to Expand Service Offering
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Research Shows CBD Can Help Combat Social Anxiety Disorder Symptoms
- Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Absence of Federal Regulations Exposes CBD Industry to Class Action Lawsuits
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) SVoD Market Opening its Doors to Low-Cost Film Content Creators
- Xalles Holdings Inc. (XALL) Partners with Automated Cryptocurrency Trading Engine to Enable Fast, Efficient Trading
- Youngevity International, Inc. (NASDAQ: YGYI) Rings Nasdaq Closing Bell as 2020 Wellness Week Company
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.